Nanoformulation of Phytochemicals to Increase Antifungal Effectiveness Against Pathogens Resistant to Drugs
DOI:
https://doi.org/10.52783/jns.v14.2861Keywords:
Lipid nanoparticles, curcumin, antifungal therapy, targeted drug delivery, fungal infections, nanotechnologyAbstract
Introduction: Drug resistance, a lack of effective alternatives, and systemic toxicity are major problems when it comes to treating fungal infections with traditional antifungal medications. Because of its low solubility and bioavailability, the bioactive chemical curcumin, which possesses antifungal and anti-inflammatory characteristics, has restricted therapeutic value. The use of lipid nanoparticles shows promise as a means to improve targeted therapy, bioavailability, and medication delivery. Using the bioactive characteristics of curcumin to improve therapeutic effectiveness while reducing side effects, this study seeks to create and characterize curcumin-loaded lipid nanoparticles (CLNs) for efficient antifungal treatment.
Materials and Methods: A solvent evaporation approach was used to create CLNs, and response surface methodology (RSM) was used for optimization. Drug release in vitro, zeta potential, entrapment efficiency, particle size, and polydispersity index (PDI) were some of the characteristics measured for the formulations. Using transmission electron microscopy (TEM), morphological examination was carried out. By employing the broth microdilution technique, the antifungal activity was assessed in relation to Aspergillus niger and Candida albicans. A variety of storage conditions were tested to determine stability.
Results: A nanoscale particle size (<200 nm), low PDI (<0.3), and a high entrapment effectiveness (>85%) were observed in the improved CLN formulation. The spherical form was confirmed by TEM scans. Research on the release of drugs in vitro showed that the release lasted for at least 48 hours. Although CLNs had lower minimum inhibitory concentrations (MICs) against fungal strains, their antifungal effectiveness was much higher compared to free curcumin. The formulation remained intact for 90 days, according to stability testing.
Conclusion: Improved bioavailability, prolonged release, and higher antifungal activity were seen in curcumin-loaded lipid nanoparticles, suggesting that they may be an efficient antifungal delivery strategy. This method has the potential to reduce systemic toxicity and overcome drug resistance, making it a viable alternative to traditional antifungal treatments.
Downloads
Metrics
References
Preez JL, Kirkland S, Leathem AJ. Fungal infections: A review of current treatment strategies. J Antimicrob Chemother. 2021;76(5):1093-1105.
Bansal A, Gupta K, Rathore MS, Tuli HS. Curcumin: A potential antifungal agent for the treatment of fungal infections. J Fungi (Basel). 2022;8(2):143.
Patel NR, Patel DA, Therape DA, Prasad R. Lipid-based nanoparticles for delivery of antifungal agents: A review. J Drug Deliv Sci Technol. 2020;57:101654.
Nayak AP, Tiyaboonchai W, Patankar S, Madhusudhan B. Design and evaluation of curcumin-loaded solid lipid nanoparticles for improved antifungal activity. Drug Dev Ind Pharm. 2021;47(2):311-319.
Ahmed TA, Aljaeid BM. Preparation, characterization, and potential application of lipid nanoparticles for drug delivery. J Drug Deliv Sci Technol. 2016;32:66-72.
Mishra V, Bansal KK, Verma A, Yadav N, Thakur S, Sudhakar K, et al. Solid lipid nanoparticles: Emerging colloidal nano drug delivery systems. Pharmaceutics. 2018;10(4):191.
Kumari S, Bhatnagar A, Sood R. Recent advances in lipid-based nanoparticles for enhanced antifungal therapy. Crit Rev Ther Drug Carrier Syst. 2023;40(1):67-92.
Shen Y, Yu J, Shen M, et al. Curcumin-based nanomedicine for antifungal therapy. J Nanobiotechnol. 2021;19(1):211.
Jain A, Jain A, Mahajan RR. Solid lipid nanoparticles: A promising approach for antifungal delivery. J Adv Res. 2022;36(1):78-90.
Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in dermal and cosmetic formulations. Adv Drug Deliv Rev. 2009;61(6):419-427.
Chaves MA, da Silva PB, Reis CP. Nanostructured lipid carriers for improving antifungal therapy. Pharm Res. 2020;37(3):45.
Souto EB, Doktorovova S. Nanostructured lipid carrier-based drug delivery systems: A state-of-the-art review. J Microencapsul. 2009;26(7):577-592.
Riva R, Ragelle H, des Rieux A, Duhem N, Jérôme C, Préat V. Chitosan and chitosan derivatives in drug delivery and tissue engineering. Adv Polym Sci. 2011;244:19-44.
Joshi M, Butola R, Soni P, Patil S. Development of lipid nanoparticle-based antifungal delivery systems: Challenges and prospects. J Drug Target. 2022;30(3):257-273.
Kaur IP, Agrawal R. Nanostructured lipid carriers (NLCs): An innovative vehicle for drug delivery. J Control Release. 2020;325(1):327-350.
Gupta M, Agrawal U, Vyas SP. Nanocarrier-based topical drug delivery for the treatment of fungal infections. J Drug Deliv Sci Technol. 2018;44:363-372.
Tadesse, Yemane, Abraha Tadese, R. C. Saini, and Rishi Pal. "Cyclic voltammetric investigation of caffeine at anthraquinone modified carbon paste electrode." International Journal of Electrochemistry 2013, no. 1 (2013): 849327.
Hooda, Mangal Sain, Rishi Pal, Anil Bhandari, and Janardhan Singh. "Antihyperglycemic and antihyperlipidemic effects of Salvadora persica in streptozotocin-induced diabetic rats." Pharmaceutical biology 52, no. 6 (2014): 745-749.
Pal, Rishi, Mangal Sain Hooda, Chain Singh Bias, and Janardhan Singh. "Hepatoprotective activity of Acacia senegal pod against carbon tetrachloride-induced hepatotoxicity in rats." International Journal of Pharmaceutical Sciences 26, no. 1 (2014): 165.
Tadese, Abraha, P. A. Subramanian, Amaha Woldu, and Rishi Pal. "Electrochemical determination and comparison of ascorbic acid in freshly prepared and bottled fruit juices: A cyclic voltammetric study." Journal of Chemical and Pharmaceutical Research 6, no. 5 (2014): 880-888.
Pal, Rishi, M. Hooda, Anil Bhandari, and Janardhan Singh. "Antioxidant potential and free radicals scavenging activity by pod extracts of acacia senegal willd." IJPCBS 2, no. 4 (2012): 500-506.
Dwivedi R, Kumar R, Srivastava A, Gupta P. Lipid nanoparticles for antifungal drug delivery: Advances and challenges. Expert Opin Drug Deliv. 2021;18(4):511-527.
Jana U, Mohanta B, Manna PK. Curcumin-loaded lipid nanoparticles for antifungal treatment: Preparation and characterization. Indian J Pharm Sci. 2019;81(4):657-665.
Sapra B, Jain S. Lipid-based nanocarriers for improved drug delivery in fungal infections. Drug Discov Today. 2020;25(5):921-930.
Shaker DS, AlSamadoni SM, Hamed MF, et al. Development and evaluation of nanostructured lipid carriers of curcumin for antifungal therapy. Pharmaceutics. 2021;13(12):2107.
Gujarathi, Nayan A., Bakliwal, Akshada A., Rane, Bhushan., Pathan, Vasim., Keservani, Raj K. Nanoencapsulated Nasal Drug Delivery System, In: Topical and Transdermal Drug Delivery Systems: Applications and Future Prospects Edited by, Nayan A. Gujarathi, Juliana Palma Abriata, Raj K. Keservani, Anil K. Sharma, Apple Academic Press, Taylor & Francis, 2022a, chap 8, pp. 235-257. ISBN: 9781774910702.
Gujarathi, Nayan A., Bakliwal, Akshada A., Rane, Bhushan., Pathan, Vasim., Keservani, Raj K. Regulatory Aspects of Drug Development for Dermal Products, In: Topical and Transdermal Drug Delivery Systems: Applications and Future Prospects Edited by, Nayan A. Gujarathi, Juliana Palma Abriata, Raj K. Keservani, Anil K. Sharma, Apple Academic Press, Taylor & Francis, 2022b, chap 10, 287-310. ISBN: 9781774910702.
Jain, Sarang Kumar., Sahu, Ankita., Keservani, Raj K. Oral Drug Delivery System: An Overview on Recent Advances in Novel Drug Delivery system, In: Advances in Novel Formulations for Drug Delivery, Edited by Raj K. Keservani, Rajesh K. Keservani, Anil K. Sharma, Scrivener Publishing-Partner with Wiley, 2023b, Chap 21, Pp. 383-400.
Jain, Sarang Kumar., Saxena Swati., Keservani, Raj K. Microspheres: An Overview on Recent Advances in Novel Drug Delivery system, In: Advances in Novel Formulations for Drug Delivery, Edited by Raj K. Keservani, Rajesh K. Keservani, Anil K. Sharma, Scrivener Publishing-Partner with Wiley, 2023a, Chap 19, Pp. 355-366.
Singh R, Lillard JW. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009;86(3):215-223.
Tamjidi F, Shahedi M, Varshosaz J, Nasirpour A. Nanostructured lipid carriers (NLC): A potential delivery system for bioactive food molecules. Innov Food Sci Emerg Technol. 2013;19:29-43.
Rizwan SB, Rades T, Boyd BJ. Lipid-based formulations for oral drug delivery: The importance of lipolysis. Adv Drug Deliv Rev. 2014;75:34-48.
Garg A, Singh S. Targeted drug delivery strategies for antifungal therapy. J Control Release. 2022;350(1):1-14.
Vishwanatha T., Sharangouda J.Patil, Satishgouda S. and Saraswati B. Patil. 2009. Antiimplantation activity of Terminalia bellirica barksextracts in rats. TSI: Biotechnology: An Indian Journal, 3(4), 257-260.
Sharangouda J. Patil, Raghuraj K., Venkatesh S., and Vishwanatha T. 2016. Progestogenic Activity of Citrus medica Seeds in Albino Rats. Proceedings in National seminar of Emerging Trends in Analytical Techniques, 01 (17), 68-72.
Sharangouda J. Patil and Saraswati B. Patil. 2013. Antiovulatory Activity of Petroleum Ether Extract Chromatographic Fractions of Citrus medica Seeds in Albino Rats. ANSInet: Journal of Medical Sciences, 13, (6), 410-417.
Sharangouda J. Patil, Venkatesh S., Vishwanatha T., Sneha R. Banagar, Ravikumar R. Banagar and Saraswati B. Patil. 2014. GCMS Analysis of bioactive constituents from the Petroleum ether extract of Citrus medica seeds. World Journal of Pharmacy and Pharmaceutical Sciences, 3, (2), 1239-1249.
Sharangouda J. Patil, Banagar S.R., Banagar R.J. and Saraswati B.Patil. 2013. Chronic Effect of Phenobarbitone Administration on Uterotrophic Activity of Albino Rats. IGRL-Indo Global Research Journal of Pharmaceutical Sciences, 3, (1), 13-16.
Sharangouda and Saraswati B. Patil. 2007. Post-coital antifertility activity of Citrus medica seeds. NEA: The Bioscan- An International Journal of Life Sciences 2(4):304-310.
Sharangouda and Saraswati B. Patil. 2007. Phytochemical screening and antifertility activity of various extracts of Citrus medica (Lemon) seeds in albino rats. Connect Journals: Advances in Pharmacology and Toxicology, 8(2):71-74.
Shruti Hirekurubar, Sharangouda J. Patil and Sanjeevkumar Giri. 2022. Synthesis, Biological Evaluation and Molecular Docking of Indole Based 1,3,4-Oxadiazol Derivative, Indian Journal of Natural Sciences, 13(73): 32852-32857.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
